Physician

Tolulope Adesiyun Agunbiade, MD

According to 2025 Medicare claims, Tolulope Agunbiade, MD (NPI: 1003115387) practices advanced heart failure and transplant cardiology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is VIRTUA MEDICAL GROUP, PA (NPI: 1649226515; TIN: 271348772) and primary practice location at 08034-2600.

Agunbiade's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 169 traditional Medicare patients, billed 483 HCPCS/CPT codes, and received $43,880 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,593 prescription claims across 189 beneficiaries totaling $4,424,831 in drug costs, led by Vyndamax (Tafamidis). DME data shows 187 claims. Open Payments data shows 35 records totaling $5,622. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $29,335 and ending at $43,880. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,543 to $4,424,831. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,402 to $6,186.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	146	407	$29,335
2019	566	1,974	$165,093
2020	568	1,770	$131,010
2021	1,469	3,134	$164,055
2022	746	1,685	$101,211
2023	162	593	$61,654
2024	169	483	$43,880

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	15	52	$4,543
2016	28	80	$6,751
2017	50	177	$16,191
2018	54	210	$21,096
2019	121	591	$125,105
2020	138	989	$214,981
2021	165	1,280	$964,765
2022	165	1,231	$1,769,828
2023	159	956	$2,194,638
2024	189	1,593	$4,424,831

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	13	$951
2020	N/R	217	$13,504
2021	N/R	54	$2,932
2022	N/R	N/R	N/R
2023	N/R	284	$23,967
2024	N/R	187	$10,120

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	47	56	$151
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	40	42	$142
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	46	107	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	66	85	$94
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	30	34	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	168	5,280	$3,919,431
Entresto	Sacubitril/Valsartan	256	10,639	$232,853
Farxiga	Dapagliflozin Propanediol	130	5,578	$100,445
Eliquis	Apixaban	101	3,960	$73,612
Jardiance	Empagliflozin	18	840	$16,313

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	68	$4,692
J2260	Injection, milrinone lactate, 5 mg	N	N/R	68	$4,450
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	51	$978

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$1,722	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$3,900	Tosoh Bioscience, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tolulope Adesiyun Agunbiade, MD?

Tedicare shows public-source Medicare data for Tolulope Adesiyun Agunbiade, MD (NPI 1003115387), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tolulope Adesiyun Agunbiade, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tolulope Adesiyun Agunbiade, MD?

Tolulope Adesiyun Agunbiade, MD is linked to VIRTUA MEDICAL GROUP, PA (billing NPI 1649226515) in the available physician profile data.

Does Tolulope Adesiyun Agunbiade, MD have Open Payments data?

Tolulope Adesiyun Agunbiade, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.